{
    "clinical_study": {
        "@rank": "127712", 
        "acronym": "LOGIN - EMDR", 
        "arm_group": [
            {
                "arm_group_label": "Eye-Movement-Desensitization-Reprocessing", 
                "arm_group_type": "Experimental", 
                "description": "Eye-Movement-Desensitization-Reprocessing"
            }, 
            {
                "arm_group_label": "Treatment as usual (control group)", 
                "arm_group_type": "No Intervention", 
                "description": "treatment as usual"
            }
        ], 
        "brief_summary": {
            "textblock": "The study explores the feasibility of Eye-Movement-Desensitization and Reprocessing (EMDR)\n      in non-specific chronic back pain."
        }, 
        "brief_title": "Eye Movement Desensitization and Reprocessing (EMDR) in Non-specific Chronic Back Pain", 
        "completion_date": {
            "#text": "July 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Non-specific Chronic Back Pain", 
        "condition_browse": {
            "mesh_term": "Back Pain"
        }, 
        "detailed_description": {
            "textblock": "The study explores the feasibility of Eye-Movement-Desensitization and Reprocessing (EMDR)\n      in non-specific chronic back pain in a randomized controlled trial (RCT) with 6 months\n      follow-up. The treatment consists of 12-sessions EMDR a 60 minutes using eye-movements for\n      bilateral stimulation in addition to treatment as usual (TAU) that is compared to TAU alone."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  >= 18 years\n\n          -  non-specific chronic low back pain >= 45 days/3 months\n\n          -  high emotional distress caused by psychological trauma\n\n          -  German language skills\n\n        Exclusion Criteria:\n\n          -  specific causes of chronic back pain\n\n          -  application for retirement pension pending\n\n          -  ongoing psychotherapy\n\n          -  severe physical or psychiatric comorbidity"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "30", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 23, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01850875", 
            "org_study_id": "01EC1010A"
        }, 
        "intervention": {
            "arm_group_label": "Eye-Movement-Desensitization-Reprocessing", 
            "intervention_name": "Eye-Movement-Desensitization-Reprocessing", 
            "intervention_type": "Behavioral"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Eye-Movement-Desensitization and Reprocessing", 
            "EMDR", 
            "Chronic back pain", 
            "CBP", 
            "treatment"
        ], 
        "lastchanged_date": "May 13, 2013", 
        "link": {
            "description": "Consortium LOGIN", 
            "url": "http://www.login-verbund.de/index.php?id=2&L=1"
        }, 
        "location": {
            "contact": {
                "email": "jonas.tesarz@med.uni-heidelberg.de", 
                "last_name": "Jonas Tesarz, Dr.", 
                "phone": "+49 6221 5637862"
            }, 
            "facility": {
                "address": {
                    "city": "Heidelberg", 
                    "country": "Germany", 
                    "state": "Baden-W\u00fcrttemberg", 
                    "zip": "69120"
                }, 
                "name": "University Hospital Heidelberg"
            }, 
            "investigator": {
                "last_name": "Wolfgang Eich, Prof. Dr.", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Germany"
        }, 
        "number_of_arms": "2", 
        "official_title": "Localized and Generalized Musculoskeletal Pain: Psychobiological Mechanisms and Implications for Treatment (LOGIN) - Subgroups Characterized by Psychological Trauma, Mental Comorbidity, and Psychobiological Patterns and Their Specialized Treatment - Eye Movement Desensitization and Reprocessing (EMDR) in Non-specific Chronic Back Pain", 
        "other_outcome": [
            {
                "measure": "functional and structural changes in fMRI", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline fMRI at average 6 months"
            }, 
            {
                "description": "Geisser et al., 1996", 
                "measure": "Change in the pain experience scale - Pain affect", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline pain experience scale levels at average 6 months"
            }, 
            {
                "description": "Kohlmann et al., 1996", 
                "measure": "Change in the Hannover functional ability questionnaire (FFbH) - disability", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline disabilty levels at average 6 months"
            }, 
            {
                "description": "According to the protocol by Rolke et al. (2006), developed within the Germany Research Network on Neuropathic Pain (DFNS)", 
                "measure": "Change in Quantitative sensory testing (QST)profiles", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline QST profile at average 6 months"
            }, 
            {
                "description": "difference in pressure pain threshold before and after oscillating heat (2 min.)", 
                "measure": "Change in Conditioned Pain Modulation", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline conditioned pain modulation activity at average 6 months"
            }, 
            {
                "description": "Plasma levels: AEA (ng/ml), 2-AG (ng/ml), AA (ng/ml), PEA (ng/ml), OEA (ng/ml), AEA (pmol/g), 2-AG (pmol/g), AA (nmol/g), PEA (pmol/g), OEA (pmol/g),", 
                "measure": "Change in Plasma endocannabinoids and lipids", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline endocannabinoids and lipids at average 6 months"
            }, 
            {
                "description": "Plasma levels in (pg/ml)", 
                "measure": "Change in plasma nerve growth factor levels", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline NGF levels at average 6 months"
            }, 
            {
                "measure": "Change in pain drawing/ the spatial extent of the pain", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline Pain extent at average 6 months"
            }, 
            {
                "description": "Flor et al., 1990", 
                "measure": "Change in West Haven-Yale multidimensional pain inventory scores", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline West Haven-Yale multidimensional pain inventory scores at average 6 months"
            }, 
            {
                "description": "von Korff er al., 1992", 
                "measure": "Change in chronic pain grade", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline chronic pain grade at average 6 months"
            }, 
            {
                "description": "Schumacher et al., 2004", 
                "measure": "Change in Resilience Scale (RS-11) scores", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline resilience scores at average 6 months"
            }, 
            {
                "description": "Zigmond & Snaith, 1983", 
                "measure": "Change in Hospital Anxiety and Depression Scale scores", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline anxiety and depression levels at average 6 months"
            }, 
            {
                "description": "SF-12", 
                "measure": "Change in Health Survey scores", 
                "safety_issue": "No", 
                "time_frame": "Change from baseline quality of life level at average 6 months"
            }, 
            {
                "description": "SCL-90R", 
                "measure": "Change in somatization scores", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline somatization scores at average 6 months"
            }, 
            {
                "measure": "Change in medication intake", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline medication intake at average 6 months"
            }, 
            {
                "description": "DES/FDS-20", 
                "measure": "Change in dissociation scores", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline dissociation at average 6 months"
            }, 
            {
                "measure": "Change in Post Traumatic Diagnostic Scale", 
                "safety_issue": "No", 
                "time_frame": "Change from Baseline post traumatic diagnostic scale levels at average 6 months"
            }, 
            {
                "measure": "Patient global impression of change", 
                "safety_issue": "No", 
                "time_frame": "after on average 6 months of treatment"
            }, 
            {
                "description": "% of patients eligible for inclusion that give written informed consent", 
                "measure": "Recruitment potential", 
                "safety_issue": "No", 
                "time_frame": "6 months"
            }, 
            {
                "description": "% of patients that finish treatment, including pre- and post-evaluation", 
                "measure": "Retention rate", 
                "safety_issue": "No", 
                "time_frame": "over average 6 months of treatment"
            }
        ], 
        "overall_contact": {
            "email": "andreas.gerhardt@med.uni-heidelberg.de", 
            "last_name": "Andreas Gerhardt, Dipl.-Psych.", 
            "phone": "+49 6221 5636860"
        }, 
        "overall_contact_backup": {
            "email": "jonas.tesarz@med.uni-heidelberg.de", 
            "last_name": "Jonas Tesarz, Dr.", 
            "phone": "+49 6221 5637862"
        }, 
        "overall_official": {
            "affiliation": "University Hospital Heidelberg", 
            "last_name": "Wolfgang Eich, Prof. Dr.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Germany: Federal Ministry of Education and Research", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Numerical rating scale 0-10", 
            "measure": "Change in pain intensity", 
            "safety_issue": "No", 
            "time_frame": "Change from Baseline Pain intensity at average 6 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01850875"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University Hospital Heidelberg", 
            "investigator_full_name": "Prof. Dr. Wolfgang Eich", 
            "investigator_title": "Prof. Dr.", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "University Hospital Heidelberg", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University Hospital Heidelberg", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2013"
    }
}